Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205.

Br J Cancer · 2013 · PMC3776974 · PMID 23963139

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a statistical trendno p-value reported

Furthermore, in a cross-trial comparison between AIO KRK 0604 ( Schmiegel et al , 2013 ) and this trial, a statistical trend towards the application of more treatment cycles in the present trial was noted.

also in 2,798 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.